Analystreport

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) was downgraded by analysts at Capital One Financial Co. from an "overweight" rating to an "equal weight" rating. They now have a $4.00 price ...

Ironwood Pharmaceuticals, Inc. - Class A  (IRWD) 
Last ironwood pharmaceuticals, inc. - class a earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.ironwoodpharma.com